Statements: Roche Consulting Limited

Canonical ID: NK-WGjbfPRSL8CGvysJWwfvnR · Entity type: LegalEntity (reference)

This table shows statement-based, sourced records from our database. For more context, learn about how OpenSanctions stores information.

Property	Value	Source dataset	Source ID	First seen
`LegalEntity:address`	P.O. Box 23596 24553-01, A2, IFZA Business Park, DSO, Dubai	us_trade_csl	`trade-csl-adfe564084901960df98e3af54cd9b80a653b8ea7352b08184c76355`	2025-08-07
`LegalEntity:address`	Suite 1702, Level 17 Boulevard Plaza Tower 1, Sheikh Mohammed Bing Rashid Boulevard, Downtown Dubai	us_trade_csl	`trade-csl-617346339ff95c25894b1290f2112688d06190f5f49b140d0580c28e`	2025-03-29
`LegalEntity:address`	Suite 904-09, Boulevard Plaza 1, Sheikh Mohammed Bin Rashid Boulevard, Downtown Burg Khalifa Dubai AE	tw_shtc	`tw-shtc-7baa4e552306601127f937faba1330c937b82a79`	2025-09-17
`LegalEntity:address`	Suite 904-09, Boulevard Plaza 1, Sheikh Mohammed Bin Rashid Boulevard, Downtown Burg Khalifa, Dubai	us_trade_csl	`trade-csl-617346339ff95c25894b1290f2112688d06190f5f49b140d0580c28e`	2025-03-29
`LegalEntity:address`	Suite 1702, Level 17 Boulevard Plaza Tower 1, Sheikh Mohammed Bing Rashid Boulevard, Downtown Dubai AE	tw_shtc	`tw-shtc-7baa4e552306601127f937faba1330c937b82a79`	2025-09-17
`LegalEntity:country`	ae	us_trade_csl	`trade-csl-adfe564084901960df98e3af54cd9b80a653b8ea7352b08184c76355`	2025-08-07
`LegalEntity:country`	ae	us_trade_csl	`trade-csl-617346339ff95c25894b1290f2112688d06190f5f49b140d0580c28e`	2025-03-29
`LegalEntity:id`	a91f746b2c4378152a44b908feaab1005e4663d0	us_trade_csl	`trade-csl-adfe564084901960df98e3af54cd9b80a653b8ea7352b08184c76355`	2025-09-01
`LegalEntity:id`	b98e33d264c4d8d9eb54b32e3dccba658daf3fe3	tw_shtc	`tw-shtc-7baa4e552306601127f937faba1330c937b82a79`	2025-09-17
`LegalEntity:id`	6c2ea1132b5d08230778cba36e0b0542067d475b	us_trade_csl	`trade-csl-617346339ff95c25894b1290f2112688d06190f5f49b140d0580c28e`	2025-09-01
`LegalEntity:name`	Roche Consulting Limited	us_trade_csl	`trade-csl-adfe564084901960df98e3af54cd9b80a653b8ea7352b08184c76355`	2025-08-07
`LegalEntity:name`	Roche Consulting Limited	tw_shtc	`tw-shtc-7baa4e552306601127f937faba1330c937b82a79`	2025-09-17
`LegalEntity:name`	Roche Consulting Limited	us_trade_csl	`trade-csl-617346339ff95c25894b1290f2112688d06190f5f49b140d0580c28e`	2025-03-29
`LegalEntity:programId`	US-BIS-EL	us_trade_csl	`trade-csl-617346339ff95c25894b1290f2112688d06190f5f49b140d0580c28e`	2025-05-16
`LegalEntity:programId`	US-BIS-EL	us_trade_csl	`trade-csl-adfe564084901960df98e3af54cd9b80a653b8ea7352b08184c76355`	2025-08-07
`LegalEntity:topics`	export.control	tw_shtc	`tw-shtc-7baa4e552306601127f937faba1330c937b82a79`	2025-09-17
`LegalEntity:topics`	export.control	us_trade_csl	`trade-csl-adfe564084901960df98e3af54cd9b80a653b8ea7352b08184c76355`	2025-09-01
`LegalEntity:topics`	export.control	us_trade_csl	`trade-csl-617346339ff95c25894b1290f2112688d06190f5f49b140d0580c28e`	2025-09-01

Previous
1 - 18 of 18
Next